Table 2.
Sample Characteristics
Total Sample (N = 114) | |
---|---|
Participant type – N (%) | |
Patient | 87 (76%) |
Caregiver | 24 (21%) |
Gender – N (%) | |
Female | 80 (70%) |
Age – mean (SE) | 53.94 (1.16) |
Years since diagnosis – mean (SE) | 4.43 (0.28) |
Lung cancer type | |
Adenocarcinoma | 81 (71%) |
Other | 32 (28%) |
Current disease stage – N (%) | |
Stage I | 4 (4%) |
Stage II | 2 (2%) |
Stage III | 3 (3%) |
Stage IV | 53 (46%) |
No evidence of disease | 49 (43%) |
Treatment received – N (%) | |
Chemotherapy | 72 (63%) |
Radiation | 50 (44%) |
Targeted therapy | 59 (52%) |
Immunotherapy | 15 (13%) |
Surgery | 54 (47%) |
Note: Caregivers reported characteristics of the patients they cared for, these are the characteristics in the table.